Literature DB >> 17597068

Cytotoxic phospholipid oxidation products. Cell death from mitochondrial damage and the intrinsic caspase cascade.

Rui Chen1, Lili Yang, Thomas M McIntyre.   

Abstract

Phospholipid oxidation products accumulate in the necrotic core of atherosclerotic lesions, in apoptotic cells, and circulate in oxidized low density lipoprotein. Phospholipid oxidation generates toxic products, but little is known about which specific products are cytotoxic, their receptors, or the mechanism(s) that induces cell death. We find the most common phospholipid oxidation product of oxidized low density lipoprotein, phosphatidylcholine with esterified sn-2-azelaic acid, induced apoptosis at low micromolar concentrations. The synthetic ether phospholipid hexadecyl azelaoyl phosphatidylcholine (HAzPC) was rapidly internalized, and overexpression of PLA2g7 (PAF acetylhydrolase) that specifically hydrolyzes such oxidized phospholipids suppressed apoptosis. Internalized HAzPC associated with mitochondria, and cytochrome c, and apoptosis-inducing factor escaped from mitochondria to the cytoplasm and nucleus, respectively, in cells exposed to HAzPC. Isolated mitochondria exposed to HAzPC rapidly swelled and released cytochrome c and apoptosis-inducing factor. Other phospholipid oxidation products induced swelling, but HAzPC was the most effective and was twice as effective as its diacyl homolog. Cytoplasmic cytochrome c completes the apoptosome, and activated caspase 9 and 3 were present in cells exposed to HAzPC. Irreversible inhibition of caspase 9 blocked downstream caspase 3 activation and prevented apoptosis. Mitochondrial damage initiated this apoptotic cascade, because overexpression of Bcl-X(L), an anti-apoptotic protein localized to mitochondria, blocked cytochrome c escape and apoptosis. Thus, exogenous phospholipid oxidation products target intracellular mitochondria to activate the intrinsic apoptotic cascade.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597068      PMCID: PMC2701377          DOI: 10.1074/jbc.M702865200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Cell death: critical control points.

Authors:  Nika N Danial; Stanley J Korsmeyer
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  The pathophysiology of mitochondrial cell death.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

3.  Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.

Authors:  P L Smiley; K E Stremler; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

Review 4.  Chemistry of free radical and singlet oxidation of lipids.

Authors:  E N Frankel
Journal:  Prog Lipid Res       Date:  1984       Impact factor: 16.195

5.  Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates.

Authors:  K E Stremler; D M Stafforini; S M Prescott; T M McIntyre
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

Review 6.  Role of AIF in caspase-dependent and caspase-independent cell death.

Authors:  Sean P Cregan; Valina L Dawson; Ruth S Slack
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

Review 7.  Apoptotic cell death in atherosclerosis.

Authors:  Trevor D Littlewood; Martin R Bennett
Journal:  Curr Opin Lipidol       Date:  2003-10       Impact factor: 4.776

8.  Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.

Authors:  Amir Ravandi; Saeid Babaei; Ramsey Leung; Juan Carlos Monge; George Hoppe; Henry Hoff; Hiroshi Kamido; Arnis Kuksis
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

9.  Identification of 2-azelaoylphosphatidylcholine as one of the cytotoxic products generated during oxyhemoglobin-induced peroxidation of phosphatidylcholine.

Authors:  H Itabe; Y Kushi; S Handa; K Inoue
Journal:  Biochim Biophys Acta       Date:  1988-09-02

10.  Temporary membrane distortion of vascular smooth muscle cells is responsible for their apoptosis induced by platelet-activating factor-like oxidized phospholipids and their degradation product, lysophosphatidylcholine.

Authors:  Kentaro Kogure; Sawa Nakashima; Akiko Tsuchie; Akira Tokumura; Kenji Fukuzawa
Journal:  Chem Phys Lipids       Date:  2003-11       Impact factor: 3.329

View more
  42 in total

1.  Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients.

Authors:  Ricardo Gehrau; Daniel Maluf; Kellie Archer; Richard Stravitz; Jihee Suh; Ngoc Le; Valeria Mas
Journal:  Mol Med       Date:  2011-04-20       Impact factor: 6.354

2.  A simplified procedure for semi-targeted lipidomic analysis of oxidized phosphatidylcholines induced by UVA irradiation.

Authors:  Florian Gruber; Wolfgang Bicker; Olga V Oskolkova; Erwin Tschachler; Valery N Bochkov
Journal:  J Lipid Res       Date:  2012-03-13       Impact factor: 5.922

3.  Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity.

Authors:  Yongxue Yao; Kathleen A Harrison; Mohammed Al-Hassani; Robert C Murphy; Samin Rezania; Raymond L Konger; Jeffrey B Travers
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

4.  Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase.

Authors:  Jinbo Liu; Rui Chen; Gopal K Marathe; Maria Febbraio; Weilin Zou; Thomas M McIntyre
Journal:  Circ Res       Date:  2010-12-23       Impact factor: 17.367

5.  Human TMEM30a promotes uptake of antitumor and bioactive choline phospholipids into mammalian cells.

Authors:  Rui Chen; Erin Brady; Thomas M McIntyre
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

6.  Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.

Authors:  Calvin Yeang; Devin Hasanally; Xuchu Que; Ming-Yow Hung; Aleksandra Stamenkovic; David Chan; Rakesh Chaudhary; Victoria Margulets; Andrea L Edel; Masahiko Hoshijima; Yusu Gu; William Bradford; Nancy Dalton; Phuong Miu; David Yc Cheung; Davinder S Jassal; Grant N Pierce; Kirk L Peterson; Lorrie A Kirshenbaum; Joseph L Witztum; Sotirios Tsimikas; Amir Ravandi
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

7.  Preferential hydrolysis of truncated oxidized glycerophospholipids by lysosomal phospholipase A2.

Authors:  Akira Abe; Miki Hiraoka; Hiroshi Ohguro; John J Tesmer; James A Shayman
Journal:  J Lipid Res       Date:  2016-12-19       Impact factor: 5.922

Review 8.  Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivation.

Authors:  Thomas M McIntyre
Journal:  Biochim Biophys Acta       Date:  2012-03-16

9.  Oxidized phosphatidylcholines facilitate phospholipid flip-flop in liposomes.

Authors:  Roman Volinsky; Lukasz Cwiklik; Piotr Jurkiewicz; Martin Hof; Pavel Jungwirth; Paavo K J Kinnunen
Journal:  Biophys J       Date:  2011-09-20       Impact factor: 4.033

10.  The role of oxidized phospholipids in atherosclerosis.

Authors:  Judith A Berliner; Norbert Leitinger; Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2008-12-04       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.